Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach (Q28280088)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach	scientific article

Statements

scholarly article

0 references

0 references

Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach (English)

0 references

1 reference

based on heuristic

inferred from title

Patrick Bossuyt

6

object named as

Patrick Bossuyt

0 references

5

object named as

Brent C Opmeer

0 references

Frank Broekmans

9

object named as

Frank J M Broekmans

0 references

Kimiko A Broeze

3

object named as

Kimiko A Broeze

0 references

Marinus Eijkemans

7

object named as

Marinus J C Eijkemans

0 references

8

object named as

Ben-Willem J Mol

0 references

author name string

Simone L Broer

1

0 references

Jeroen van Disseldorp

2

0 references

Madeleine Dolleman

4

0 references

language of work or name

0 references

publication date

2013

1 reference

Human Reproduction Update

0 references

19

0 references

1

0 references

26-36

0 references

Follicle stimulating hormone as a predictor of ovarian response in women undergoing controlled ovarian hyperstimulation for IVF.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

Deep phenotyping to predict live birth outcomes in in vitro fertilization

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

Age-specific levels for basal follicle-stimulating hormone assessment of ovarian function

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

What can the clinician do to improve implantation?

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

A systematic review of tests predicting ovarian reserve and IVF outcome

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

Anti-mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

Individual patient data meta-analysis of diagnostic and prognostic studies in obstetrics, gynaecology and reproductive medicine

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

Individual patient data meta-analysis: a promising approach for evidence synthesis in reproductive medicine

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

Basal FSH concentration as a predictor of IVF outcome in older women undergoing stimulation with GnRH antagonist.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

Effect of embryo quality on pregnancy outcome following single embryo transfer in women with a diminished egg reserve.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

Antimüllerian hormone serum levels: a putative marker for ovarian aging

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

Comparison of basal and clomiphene citrate induced FSH and inhibin B, ovarian volume and antral follicle counts as ovarian reserve tests and predictors of poor ovarian response in IVF.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

A prospective randomized clinical trial of differing starter doses of recombinant follicle-stimulating hormone (follitropin-beta) for first time in vitro fertilization and intracytoplasmic sperm injection treatment cycles

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

The combined effect of age and basal follicle-stimulating hormone on the cost of a live birth at assisted reproductive technology

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

Does 3D ultrasound offer any advantage in the pretreatment assessment of ovarian reserve and prediction of outcome after assisted reproduction treatment?

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

The antral follicle count is a better marker than basal follicle-stimulating hormone for the selection of older patients with acceptable pregnancy prospects after in vitro fertilization

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

Comparison of endocrine tests with respect to their predictive value on the outcome of ovarian hyperstimulation in IVF treatment: results of a prospective randomized study

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

Anti-Müllerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

Anti-Müllerian hormone-based prediction model for a live birth in assisted reproduction.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

Systematic reviews of diagnostic test accuracy

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

Increased gonadotrophin stimulation does not improve IVF outcomes in patients with predicted poor ovarian reserve.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

Predicting ongoing pregnancy chances after IVF and ICSI: a national prospective study.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

Elevated day 3 follicle-stimulating hormone/luteinizing hormone ratio >or= 2 is associated with higher rates of cancellation in in vitro fertilization-embryo transfer cycles.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

Moderately elevated levels of basal follicle-stimulating hormone in young patients predict low ovarian response, but should not be used to disqualify patients from attempting in vitro fertilization.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

Cumulative live-birth rates after in vitro fertilization.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

Prediction of ovarian response and IVF/ICSI outcome by three-dimensional ultrasonography and power Doppler angiography.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

Predicting live birth, preterm delivery, and low birth weight in infants born from in vitro fertilisation: a prospective study of 144,018 treatment cycles

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

Serum anti-Müllerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles--implications for individualization of therapy

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

The significance of the number of antral follicles prior to stimulation in predicting ovarian responses in an IVF programme.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

Antral follicle count and FSH concentration after clomiphene citrate challenge test in the prediction of ovarian response during IVF treatment

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

Individualizing FSH dose for assisted reproduction using a novel algorithm: the CONSORT study

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

A prospective randomized clinical trial comparing an individual dose of recombinant FSH based on predictive factors versus a 'standard' dose of 150 IU/day in 'standard' patients undergoing IVF/ICSI treatment

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

A prospective study of predictive factors of ovarian response in 'standard' IVF/ICSI patients treated with recombinant FSH. A suggestion for a recombinant FSH dosage normogram

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

The predictive value for in vitro fertility delivery rates is greatly impacted by the method used to select the threshold between normal and elevated basal follicle-stimulating hormone.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

Antimüllerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracyoplasmic sperm injection.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

Clinical outcomes in relation to the daily dose of recombinant follicle-stimulating hormone for ovarian stimulation in in vitro fertilization in presumed normal responders younger than 39 years: a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

Pituitary suppression regimens in poor responders undergoing IVF treatment: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

Clinical management of low ovarian response to stimulation for IVF: a systematic review

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

Pretreatment transvaginal ultrasound examination predicts ovarian responsiveness to gonadotrophins in in-vitro fertilization.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

Relationship of serum antimüllerian hormone concentration to age at menopause

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

Anti-müllerian hormone is a promising predictor for the occurrence of the menopausal transition

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

Obesity and Clomiphene Challenge Test as predictors of outcome of in vitro fertilization and intracytoplasmic sperm injection.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

The accuracy of multivariate models predicting ovarian reserve and pregnancy after in vitro fertilization: a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

Mean ovarian diameter (MOD) as a predictor of poor ovarian response.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

Prognostic value of some ovarian reserve tests in poor responders

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

Prospective analysis of the relationships between the ovarian follicle cohort and basal FSH concentration, the inhibin response to exogenous FSH and ovarian follicle number at different stages of the normal menstrual cycle and after pituitary down-r

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS041

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28280088&oldid=1927976433"